Cargando…

Octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: A pilot study

BACKGROUND: Pharyngocutaneous fistula (PCF) and salivary leaks are well known complications of head and neck surgery. The medical management of PCF has included the use of octreotide without a well‐defined understanding of its therapeutic mechanism. We hypothesized that octreotide induces alteration...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Jonathan, Reed, William, Foster, Matthew W., Kahmke, Russel R., Rocke, Daniel J., Puscas, Liana, Cannon, Trinitia Y., Lee, Walter T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948565/
https://www.ncbi.nlm.nih.gov/pubmed/36846407
http://dx.doi.org/10.1002/lio2.962
_version_ 1784892807812481024
author Cohen, Jonathan
Reed, William
Foster, Matthew W.
Kahmke, Russel R.
Rocke, Daniel J.
Puscas, Liana
Cannon, Trinitia Y.
Lee, Walter T.
author_facet Cohen, Jonathan
Reed, William
Foster, Matthew W.
Kahmke, Russel R.
Rocke, Daniel J.
Puscas, Liana
Cannon, Trinitia Y.
Lee, Walter T.
author_sort Cohen, Jonathan
collection PubMed
description BACKGROUND: Pharyngocutaneous fistula (PCF) and salivary leaks are well known complications of head and neck surgery. The medical management of PCF has included the use of octreotide without a well‐defined understanding of its therapeutic mechanism. We hypothesized that octreotide induces alterations in the saliva proteome and that these alterations may provide insight into the mechanism of action underlying improved PCF healing. We undertook an exploratory pilot study in healthy controls that involved collecting saliva before and after a subcutaneous injection of octreotide and performing proteomic analysis to determine the effects of octreotide. METHODS: Four healthy adult participants provided saliva samples before and after subcutaneous injection of octreotide. A mass‐spectrometry based workflow optimized for the quantitative proteomic analysis of biofluids was then employed to analyze changes in salivary protein abundance after octreotide administration. RESULTS: There were 3076 human, 332 Streptococcus mitis, 102 G. haemolyans, and 42 Granulicatella adiacens protein groups quantified in saliva samples. A paired statistical analysis was performed using the generalized linear model (glm) function in edgeR. There were and ~300 proteins that had a p < .05 between the pre‐ and post‐octreotide groups ~50 proteins with an FDR‐corrected p < .05 between pre‐ and post‐groups. These results were visualized using a volcano plot after filtering on proteins quantified by 2 more or unique precursors. Both human and bacterial proteins were among the proteins altered by octreotide treatment. Notably, four isoforms of the human cystatins, belonging to a family of cysteine proteases, that had significantly lower abundance after treatment. CONCLUSION: This pilot study demonstrated octreotide‐induced downregulation of cystatins. By downregulation of cystatins in the saliva, there is decreased inhibition of cysteine proteases such as Cathepsin S. This results in increased cysteine protease activity that has been linked to enhanced angiogenic response, cell proliferation and migration that have resulted in improved wound healing. These insights provide first steps at furthering our understanding of octreotide's effects on saliva and reports of improved PCF healing.
format Online
Article
Text
id pubmed-9948565
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-99485652023-02-24 Octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: A pilot study Cohen, Jonathan Reed, William Foster, Matthew W. Kahmke, Russel R. Rocke, Daniel J. Puscas, Liana Cannon, Trinitia Y. Lee, Walter T. Laryngoscope Investig Otolaryngol Head and Neck, and Tumor Biology BACKGROUND: Pharyngocutaneous fistula (PCF) and salivary leaks are well known complications of head and neck surgery. The medical management of PCF has included the use of octreotide without a well‐defined understanding of its therapeutic mechanism. We hypothesized that octreotide induces alterations in the saliva proteome and that these alterations may provide insight into the mechanism of action underlying improved PCF healing. We undertook an exploratory pilot study in healthy controls that involved collecting saliva before and after a subcutaneous injection of octreotide and performing proteomic analysis to determine the effects of octreotide. METHODS: Four healthy adult participants provided saliva samples before and after subcutaneous injection of octreotide. A mass‐spectrometry based workflow optimized for the quantitative proteomic analysis of biofluids was then employed to analyze changes in salivary protein abundance after octreotide administration. RESULTS: There were 3076 human, 332 Streptococcus mitis, 102 G. haemolyans, and 42 Granulicatella adiacens protein groups quantified in saliva samples. A paired statistical analysis was performed using the generalized linear model (glm) function in edgeR. There were and ~300 proteins that had a p < .05 between the pre‐ and post‐octreotide groups ~50 proteins with an FDR‐corrected p < .05 between pre‐ and post‐groups. These results were visualized using a volcano plot after filtering on proteins quantified by 2 more or unique precursors. Both human and bacterial proteins were among the proteins altered by octreotide treatment. Notably, four isoforms of the human cystatins, belonging to a family of cysteine proteases, that had significantly lower abundance after treatment. CONCLUSION: This pilot study demonstrated octreotide‐induced downregulation of cystatins. By downregulation of cystatins in the saliva, there is decreased inhibition of cysteine proteases such as Cathepsin S. This results in increased cysteine protease activity that has been linked to enhanced angiogenic response, cell proliferation and migration that have resulted in improved wound healing. These insights provide first steps at furthering our understanding of octreotide's effects on saliva and reports of improved PCF healing. John Wiley & Sons, Inc. 2022-11-28 /pmc/articles/PMC9948565/ /pubmed/36846407 http://dx.doi.org/10.1002/lio2.962 Text en © 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Head and Neck, and Tumor Biology
Cohen, Jonathan
Reed, William
Foster, Matthew W.
Kahmke, Russel R.
Rocke, Daniel J.
Puscas, Liana
Cannon, Trinitia Y.
Lee, Walter T.
Octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: A pilot study
title Octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: A pilot study
title_full Octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: A pilot study
title_fullStr Octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: A pilot study
title_full_unstemmed Octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: A pilot study
title_short Octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: A pilot study
title_sort octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: a pilot study
topic Head and Neck, and Tumor Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948565/
https://www.ncbi.nlm.nih.gov/pubmed/36846407
http://dx.doi.org/10.1002/lio2.962
work_keys_str_mv AT cohenjonathan octreotidemayimprovepharyngocutaneousfistulahealingthroughdownregulationofcystatinsapilotstudy
AT reedwilliam octreotidemayimprovepharyngocutaneousfistulahealingthroughdownregulationofcystatinsapilotstudy
AT fostermattheww octreotidemayimprovepharyngocutaneousfistulahealingthroughdownregulationofcystatinsapilotstudy
AT kahmkerusselr octreotidemayimprovepharyngocutaneousfistulahealingthroughdownregulationofcystatinsapilotstudy
AT rockedanielj octreotidemayimprovepharyngocutaneousfistulahealingthroughdownregulationofcystatinsapilotstudy
AT puscasliana octreotidemayimprovepharyngocutaneousfistulahealingthroughdownregulationofcystatinsapilotstudy
AT cannontrinitiay octreotidemayimprovepharyngocutaneousfistulahealingthroughdownregulationofcystatinsapilotstudy
AT leewaltert octreotidemayimprovepharyngocutaneousfistulahealingthroughdownregulationofcystatinsapilotstudy